/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Cingulate Inc Share Price Today: Live Updates & Key Insights

Cingulate Inc share price today is $4.6291, up -4.13%. The stock opened at $4.85 against the previous close of $4.84, with an intraday high of $4.85 and low of $4.61.

Cingulate Inc Share Price Chart

style
pb-0

Cingulate Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Cingulate Inc Share Price Performance

$4.6291 -0.0413(-4.13%) CING at 27 Jul 2026 02:26 PM Biotechnology
Lowest Today 4.61
Highest Today 4.85
Today’s Open 4.85
Prev. Close 4.84
52 Week High 11.89
52 Week Low 3.16
Day’s Range: Low 4.61 High 4.85
52-Week Range: Low 3.16 High 11.89
1 day return -
1 Week return +0.87
1 month return -6.84
3 month return -11.8
6 month return -8.4
1 year return -11.8
3 year return -62.66
5 year return -94.77
10 year return -

Cingulate Inc Institutional Holdings

Vanguard Total Stock Mkt Idx Inv 2.93

Vanguard Capital Management, LLC 2.29

Vanguard Institutional Extnd Mkt Idx Tr 1.19

Vanguard Group Inc 1.12

Kestra Advisory Services, LLC 1.04

Geode Capital Management, LLC 0.75

Marshall Wace Asset Management Ltd 0.69

Jane Street Group LLC 0.67

XTX Topco Ltd 0.40

BCV Asset Management Inc. 0.38

Vanguard Fiduciary Trust Co 0.37

Fidelity Extended Market Index 0.32

Quadrature Capital Limited 0.26

HRT FINANCIAL LLC 0.25

Renaissance Technologies Corp 0.24

iShares Micro-Cap ETF 0.21

State Street Corp 0.20

Virtu Financial LLC 0.20

BlackRock Inc 0.17

Blackrock Extended Mkt Fund CF 0.17

Fidelity Total Market Index 0.17

Northern Trust Corp 0.17

Prospera Financial Services Inc 0.16

BlackRock Extended Equity Market Fund K 0.14

Chicago Partners Investment Group LLC 0.14

NT Ext Equity Mkt Index Fund - Lending 0.12

Soltis Investment Advisors, LLC 0.12

NT Ext Equity Mkt Index Fund - NL 0.10

Mariner Wealth Advisors LLC 0.10

Spartan Extended Market Index Pool F 0.08

Fidelity Series Total Market Index 0.08

Vanguard Instl Ttl Stk Mkt Idx InstlPls 0.08

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.07

Northern Trust Extended Eq Market Idx 0.07

Fidelity Nasdaq Composite Index 0.06

Vanguard Instl Ttl Stck Mkt Index Trust 0.05

Vanguard Balanced Index Inv 0.04

Spartan Total Market Index Pool G 0.04

Vanguard U.S. Eq Idx £ Acc 0.04

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.03

Cingulate Inc Market Status

Strong Buy: 1

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Cingulate Inc Fundamentals

Market Cap 65.19 M

PB Ratio 3.4556

PE Ratio 0.0

Enterprise Value 46.73 M

Total Assets 15.07 M

Volume 78013

Cingulate Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-21205277 -21.2M, FY22:-17850232 -17.9M, FY21:-20740493 -20.7M, FY20:-7283867 -7.3M, FY19:-11445336 -11.4M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:-121185 -0.1M, Q3/2025:-106782 -0.1M, Q2/2025:-146989 -0.1M, Q1/2025:-165291 -0.2M, Q3/2024:-3282087000 -3282.1M

Quarterly Net worth Q1/2026:-9312089 -9.3M, Q3/2025:-7341062 -7.3M, Q2/2025:-4788735 -4.8M, Q1/2025:-3802691 -3.8M, Q3/2024:-3231604000 -3231.6M

About Cingulate Inc & investment objective

Company Information Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

Organisation Biotechnology

Employees 14

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Cingulate Inc FAQs

What is the share price of Cingulate Inc today?

The current share price of Cingulate Inc is $4.6291.

Can I buy Cingulate Inc shares in India?

Yes, Indian investors can buy Cingulate Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Cingulate Inc shares in India?

You can easily invest in Cingulate Inc shares from India by:

Can I buy fractional shares of Cingulate Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Cingulate Inc?

Cingulate Inc has a market cap of $65.19 M.

In which sector does Cingulate Inc belong?

Cingulate Inc operates in the Biotechnology sector.

What documents are required to invest in Cingulate Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Cingulate Inc?

The PE ratio of Cingulate Inc is N/A and the PB ratio is 3.46.